Clinical Trial Update: Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy every 2 weeks with or without pegfilgrastim in advanced or metastatic colon cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Colon Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-01-06